WR

Wantesh Raj

Active Director Director DIN 07340792
DIN 07340792 First appointment Nov 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2015
Shareholding value •••• Premium profile

About Wantesh Raj

Data last updated:

Wantesh Raj is a Director at Green Med Pharma Private Limited (since 2015). The company operates in Chemicals. Green Med Pharma Private Limited reported revenue of ₹24.6 Lakh (FY 2025).

DIN 07340792
Primary Designation Director
Industry Chemicals
First Appointment 18 Nov 2015
Oldest Company Age 11 yrs
Largest company Green Med Pharma Private Limited · ₹24.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Green Med Pharma Private Limited U36100BR2015PTC025351
Director18 Nov 20152015₹24.6 Lakh (FY 2025)Active

Board colleagues of Wantesh Raj

Directorship timeline

Open interactive timeline →
Green Med Pharma Private Limited
Premium access

Shareholding and investment profile for Wantesh Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wantesh Raj

Wantesh Raj currently holds 1 directorship: Green Med Pharma Private Limited (Director, since 18 Nov 2015, revenue ₹24.6 Lakh (FY 2025)).

Wantesh Raj was first appointed on 18 Nov 2015 as Director at Green Med Pharma Private Limited.

The current boards of Wantesh Raj's companies include Amit Kumar (Green Med Pharma Private Limited), Jyotishankar Kashyap (Green Med Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available